University of Edinburgh-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044

2015

  1. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

    Annals of Oncology, Vol. 26, Núm. 7, pp. 1280-1291